Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Cavaletti

Showing results (231-240 of 261) with videos related to

Pageof 27
Sort By:
Muscle & Nerve|July 23, 2016
Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathyJennifer S Gewandter, Laurie Burke, Guido Cavaletti, et al.
Neurology|June 3, 2021
Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral NeurotoxicityPaola Alberti, Davide P Bernasconi, David R Cornblath, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 20, 2022
Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian databaseGiuseppe Liberatore, Alberto De Lorenzo, Claudia Giannotta, et al.
Cancer Research|December 2, 2017
Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term RecoveryKrystyna M Wozniak, James J Vornov, Ying Wu, et al.
Neurology|July 29, 2018
Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendationsJennifer S Gewandter, Joanna Brell, Guido Cavaletti, et al.
The Journal of Clinical Investigation|January 17, 2018
OATP1B2 deficiency protects against paclitaxel-induced neurotoxicityAlix F Leblanc, Jason A Sprowl, Paola Alberti, et al.
Archives of Toxicology|September 8, 2019
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotectionAnna Hucke, Markus M Rinschen, Oliver B Bauer, et al.
Hypertension (Dallas, Tex. : 1979)|September 21, 2011
Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trialPiero Ruggenenti, Giuseppe Lauria, Ilian Petrov Iliev, et al.
Nature Communications|March 17, 2016
A phosphotyrosine switch regulates organic cation transportersJason A Sprowl, Su Sien Ong, Alice A Gibson, et al.
British Journal of Pharmacology|May 28, 2026
Shared and specific molecular mechanisms of proteasome inhibitors in chemotherapy-induced peripheral neurotoxicityFederico Iseppon, Alessio Malacrida, Alessia Chiorazzi, et al.
Pageof 27

Showing results (231-240 of 261) with videos related to

Sort By:
Pageof 27
Muscle & Nerve|July 23, 2016
Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathyJennifer S Gewandter, Laurie Burke, Guido Cavaletti, et al.
Neurology|June 3, 2021
Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral NeurotoxicityPaola Alberti, Davide P Bernasconi, David R Cornblath, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 20, 2022
Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian databaseGiuseppe Liberatore, Alberto De Lorenzo, Claudia Giannotta, et al.
Cancer Research|December 2, 2017
Peripheral Neuropathy Induced by Microtubule-Targeted Chemotherapies: Insights into Acute Injury and Long-term RecoveryKrystyna M Wozniak, James J Vornov, Ying Wu, et al.
Neurology|July 29, 2018
Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendationsJennifer S Gewandter, Joanna Brell, Guido Cavaletti, et al.
The Journal of Clinical Investigation|January 17, 2018
OATP1B2 deficiency protects against paclitaxel-induced neurotoxicityAlix F Leblanc, Jason A Sprowl, Paola Alberti, et al.
Archives of Toxicology|September 8, 2019
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotectionAnna Hucke, Markus M Rinschen, Oliver B Bauer, et al.
Hypertension (Dallas, Tex. : 1979)|September 21, 2011
Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trialPiero Ruggenenti, Giuseppe Lauria, Ilian Petrov Iliev, et al.
Nature Communications|March 17, 2016
A phosphotyrosine switch regulates organic cation transportersJason A Sprowl, Su Sien Ong, Alice A Gibson, et al.
British Journal of Pharmacology|May 28, 2026
Shared and specific molecular mechanisms of proteasome inhibitors in chemotherapy-induced peripheral neurotoxicityFederico Iseppon, Alessio Malacrida, Alessia Chiorazzi, et al.
Pageof 27